This special supplement to The Journal of Nuclear Medicine is a detailed tabulation of
literature on FDG PET in oncology (1993–June 2000), cardiology (1986–June 2000), and …

The demographics of aging suggest a great need for the early diagnosis of dementia and
the development of preventive strategies. Neuropathology and structural MRI studies have …

Advances in therapeutic strategies for Alzheimer's disease that lead to even small delays in
onset and progression of the condition would significantly reduce the global burden of the …

A new diagnostic indicator of FDG PET scan abnormality, based on age-adjusted t statistics
and an automated voxel-based procedure, is presented and validated in a large data set …

Objective.—Cerebral parietal hypometabolism and left-right asymmetry occur early in the
course of Alzheimer disease (AD), and the apolipoprotein E type 4 alal-(APOEε4) is a risk …

Mild Alzheimer's disease (AD) is often difficult to differentiate from mild cognitive impairment
(MCI) or non-AD dementias. A multitude of diagnostic biomarkers and advanced imaging …

The purpose of this study was to confirm with pathologic verification 2 beliefs related to
Alzheimer's disease (AD):(a) the long-standing impression that bilateral temporo-parietal …

Scientific evidence concerning the subacute and long-term effects of coronavirus disease
2019 (COVID-19) is on the rise. It has been established that infection by serious acute …

In mostly small single-center studies, Alzheimer's disease (AD) is associated with
characteristic and progressive reductions in fluorodeoxyglucose positron emission …

This review addresses the specific contributions of nuclear medicine techniques, and
especially positron emission tomography (PET), for diagnosis and management of brain …